Affiliation:
1. Department of Radiotherapy, Shuguang Hospital Affiliated to Shanghai University of Chinese Traditional Medicine, Zhang Heng
Road, Pudong New Area, Shanghai 201203, China
2. Department of Oncology, Chinese Medicine Hospital of Wujin, Changzhou
213100, China
Abstract
Background:
Recent studies have shown that XihuangWan (XHW) is a kind of Chinese medicine
with significant anti-tumor and anti-inflammatory activities. However, its mechanism for preventing and treating
radiation proctitis in rectal cancer patients during radiotherapy remains unclear.
Methods:
This study employed the network pharmacology to establish a “drug-active ingredient-target genedisease”
network via using TCMSP, SymMap, GeneCard, and OMIM databases. The PPI network was conducted
by the String tool. The core targets of XHW in the treatment of rectal cancer and radiation enteritis
were identified by topological analysis, and the functional annotation analysis and pathway enrichment analysis
were performed.
Results:
A total of 61 active ingredients of XHW ingredients, 4607 rectal cancer-related genes, 5803 radiation
enteritis-related genes, and 68 common targets of XHW in the treatment of rectal cancer and radiation enteritis
were obtained. PTGS1 and NR3C2, as identified potential targets, were significantly associated with OS of colorectal
cancer patients. GO and KEGG enrichment analysis showed that bioinformatics annotation of these
common genes was mainly involved in DNA-binding transcription factor, PI3K/Akt, TNF, HIF-1 signaling
pathway, and colorectal cancer pathway.
Conclusion:
The active ingredients of XHW, mainly including Quercetin, Ellagic acid, and Stigmasterol,
might act on common targets of rectal cancer and radiation enteritis, such as PTGS1, NR3C2, IL-6, EGFR,
HIF-1A, CASP3, BCL2, ESR1, MYC, and PPARG, and regulate multiple signaling pathways like PI3K-Akt,
TNF, and HIF-1 to inhibit tumor proliferation, tumor angiogenesis, inflammatory responses, and oxidative
stress, thereby achieving prevention and treatment of radiation enteritis in rectal cancer patients during radiotherapy.
It provided an important reference for further elucidating the anti-inflammation and anti-tumor mechanism
and clinical application of XHW.
Funder
Shanghai Health Commission
Science and Technology Development Project of Shanghai University of Traditional Chinese Medicine
Integrated Chinese and Western Medicine Project of Shuguang Hospital affiliated with Shanghai University of Traditional Chinese Medicine
The Research Project of Cutting-edge Tumor Support Therapy
Publisher
Bentham Science Publishers Ltd.